This is a $756,418,674.67 definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Regeneron Pharmaceuticals Inc. The contract is for pharmaceutical and drug products, as well as large-scale production of therapeutics to support national emergency preparedness, such as the COVID-19 pandemic response.
The contract does not have a set-aside designation. Regeneron has received other high-value contracts from government agencies like the Department of Defense and Department of Veterans Affairs for pharmaceutical and medical product development and manufacturing. As a major pharmaceutical company, Regeneron has expanded its services from supplying specific drugs to providing large-scale therapeutic production capabilities to support federal public health initiatives.
The contract includes several subcontractors providing a range of services such as clinical labeling, storage, fill and finish manufacturing, regulatory support, and various testing and validation activities. Key subcontractors include Fisher Clinical Services Inc., Catalent Indiana LLC, Rondo-Pak LLC, EMD Millipore Corp, Wuxi Apptec Inc., and Bioreliance Corporation.
Generated 12/7/24, 9:48 AM